Salivary Gland Disorders
Sjögren Syndrome
aka SS
Chronic autoimmune exocrinopathy targeting lacrimal and salivary glands, producing xerostomia and xerophthalmia; carries a 15–20× increased risk of MALT lymphoma.
§ overviewOverview
Systemic autoimmune disease characterised by lymphocytic infiltration and progressive destruction of exocrine glands, principally salivary and lacrimal.
§ icdICD Classification
M35.0
§ epidemiologyEpidemiology
F:M 9:1; peak 40–60 y; second most common autoimmune rheumatic disease.
§ clinicalClinical Features
- 01Xerostomia: burning mouth, difficulty swallowing dry food, rampant caries
- 02Xerophthalmia: gritty eyes, keratoconjunctivitis sicca
- 03Bilateral parotid enlargement
- 04Fissured/depapillated tongue
- 05Extra-glandular: arthralgia, Raynaud, interstitial lung disease, neuropathy
§ histopathHistopathology
- 01Labial minor salivary gland biopsy: focal lymphocytic sialadenitis with ≥1 focus (50 lymphocytes) per 4 mm² of glandular tissue
§ investigationsInvestigations
- 01ACR/EULAR 2016 criteria (score ≥ 4): Focus score ≥ 1 on labial gland biopsy (3), anti-SSA/Ro (3), ocular staining score ≥ 5 (1), Schirmer ≤ 5 mm/5 min (1), unstimulated whole salivary flow ≤ 0.1 mL/min (1)
- 02Anti-Ro/SSA (60–70%), anti-La/SSB (40%)
- 03Elevated ESR, hypergammaglobulinaemia
- 04Sialography (fruit-laden branchless tree), sialoscintigraphy, US of parotid
§ classificationClassification
- 01Primary SS (isolated)
- 02Secondary SS (associated with RA, SLE, systemic sclerosis)
§ treatmentTreatment
- 01Symptomatic sicca: artificial tears, saliva substitutes, sugar-free gum
- 02Muscarinic agonists (pilocarpine 5 mg qid, cevimeline)
- 03Systemic: hydroxychloroquine for arthralgia/fatigue; immunosuppression (methotrexate, rituximab) for severe extra-glandular disease
- 04Aggressive caries prevention: fluoride, chlorhexidine, sialogogues
§ complicationsComplications
- 01Rampant cervical caries
- 02Candidiasis
- 03Non-Hodgkin MALT lymphoma of parotid (15–20× risk) — persistent unilateral swelling warrants biopsy
- 04Corneal ulceration
§ prognosisPrognosis
Chronic; excellent with symptom control. Life expectancy near normal unless lymphoma develops.
§ examKey Examination Points
- 01Salivary flow test, Schirmer test, focus score biopsy
- 02Persistent unilateral parotid mass → exclude lymphoma
§ revisionQuick Revision Summary
- 01Focus score ≥1 · anti-Ro/SSA · pilocarpine · watch for MALT lymphoma
§ vivaBDS Viva Questions
- 01ACR/EULAR criteria?
- 02Focus score?
- 03Lymphoma risk?
§ mcqsMCQs — Assessment (3)
Question 1
Autoantibodies most specific for SS:
Question 2
A minor salivary gland focus consists of ≥:
Question 3
Increased risk of which malignancy:
References
- Shiboski CH. ACR/EULAR 2016 Classification Criteria
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.